Z-1616-2023 Class III Ongoing

Recalled by Olympus Corporation Of The Americas — Center Valley, PA

FDA device recall Z-1616-2023 was initiated by Olympus Corporation Of The Americas on Mar 31, 2023 and is designated Class III. Reason for recall: Product non-conformance pertaining to the angle of the needle does not meet manufacturing specifications and remained unbent, resulting to slight resistance experienced during needle advancement and… The recall status is ongoing. Affected quantity: 1297 (Boxes; 5 per Box).

Recall details

Product Type
Devices
Report Date
May 31, 2023
Initiation Date
Mar 31, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1297 (Boxes; 5 per Box)

Product description

To be used with ultrasound endoscopes for ultrasound guided fine needle aspiration (FNA) of submucosal and extramural lesions of the tracheobronchial tree and the gastrointestinal tract Models: NA-U401SX-4022, NA-U401SX-4022-A

Reason for recall

Product non-conformance pertaining to the angle of the needle does not meet manufacturing specifications and remained unbent, resulting to slight resistance experienced during needle advancement and retraction.

Distribution pattern

Natiowide Foreign: Canada, Germany

Code information

UDI: 04953170388286 Lot numbers: KR248740 KR248746 KR252863 KR253666 KR253681 KR260854 KR260865 KR260873 KR260875 KR260876 KR260877 KR260896 KR260917 KR260937

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1616-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1616-2023. Report a data issue: hello@regdatalab.com.